The burden of Comorbidity in people with chronic kidney disease stage 3: A cohort study

BMC Nephrology

Volumn 16, Issue 1, 2015, Pages

  Fraser, Simon D S ^a   Roderick, Paul J ^a   May, Carl R ^b   McIntyre, Natasha ^c   McIntyre, Christopher ^d   Fluck, Richard J ^c   Shardlow, Adam ^d   Taal, Maarten W ^d  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c ROYAL DERBY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Chronic kidney disease; Comorbidity; Mortality; Multimorbidity; Polypharmacy

Indexed keywords

ADULT; AGE; AGED; ANEMIA; ARTICLE; BLOOD SAMPLING; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; EDUCATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; PRIMARY MEDICAL CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SELF REPORT; SMOKING; THYROID DISEASE; URINE SAMPLING; VERY ELDERLY; AGE DISTRIBUTION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; EDUCATIONAL STATUS; EPIDEMIOLOGY; MIDDLE AGED; PRIMARY HEALTH CARE; RISK FACTOR; SEX RATIO; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; UNITED KINGDOM;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANEMIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEX DISTRIBUTION; SMOKING; SURVIVAL RATE; UNITED KINGDOM;

EID: 84949024216     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/s12882-015-0189-z     Document Type: Article

References (42)

1. KDIGO. 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):150.
2. National Institute for Health and Clinical Excellence guideline 182; Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care. London, National Institute of Health and Care Excellence, 2014.
3. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37-43.
4. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, et al. Associations of kidney disease measures with mortality and endstage renal disease in individuals with and without hypertension: a metaanalysis. Lancet. 2012;380:1649-61.
5. Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380:1662-73.
6. Jesky M, Lambert A, Burden AC, Cockwell P. The impact of chronic kidney disease and cardiovascular comorbidity on mortality in a multiethnic population: a retrospective cohort study. BMJ Open. 2013;3:e003458.
7. May CR, Eton DT, Boehmer K, Gallacher K, Hunt K, MacDonald S, et al. Rethinking the patient: using burden of treatment theory to understand the changing dynamics of illness. BMC Health Serv Res. 2014;14:281.
8. Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol. 2012;65:1041-51.
9. Gallacher KI, Batty GD, McLean G, Mercer SW, Guthrie B, May CR, et al. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1, 424, 378 patients in Scotland: implications for treatment burden. BMC Med. 2014;12:151.
10. Dusseux E, Albano L, Fafin C, Hourmant M, Guérin O, Couchoud C, et al. A simple clinical tool to inform the decision-making process to refer elderly incident dialysis patients for kidney transplant evaluation. Kidney Int. 2015;88(1):121-9.
11. Miskulin D, Bragg-Gresham J, Gillespie BW, Tentori F, Pisoni RL, Tighiouart H, et al. Key comorbid conditions that are predictive of survival among hemodialysis patients. Clin J Am Soc Nephrol. 2009;4(11):1818-26.
12. Stevens PE, de Lusignan S, Farmer CK, Tomson CR. Engaging primary care in CKD initiatives: the UK experience. Nephrol Dial Transplant. 2012;27 Suppl 3:S5-11.
13. McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clin J Am Soc Nephrol. 2011;6:2356-63.
14. The World Health Organization and International Diabetes Federation. The Definition and Diagnosis of Diabetes Mellitus and Intermediate Glycaemia. WHO Press. World Health Organisation, Geneva, Switzerland 2006.
15. Jordan H, Roderick P, Martin D. The index of multiple deprivation 2000 and accessibility effects on health. J Epidemiol Community Health. 2004;58:250-7.
16. Grundy E, Holt G. The socioeconomic status of older adults: how should we measure it in studies of health inequalities? J Epidemiol Community Health. 2001;55:895-904.
17. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro 3rd AF, Feldman HI, et al. A new equation to estimate Glomerular Filtration Rate. Ann Intern Med. 2009;150:604-12.
18. Pinto-Sietsma SJ, Navis G, Janssen WMT, de Zeeuw D, Gans RO, de Jong PE, et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis. 2003;41:733-41.
19. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004;328:1519.
20. van Nooten FE, Green J, Brown R, Finkelstein FO, Wish J. Burden of illness for patients with non-dialysis chronic kidney disease and anemia in the United States: review of the literature. J Med Econ. 2010;13:241-56.
21. Khan IH. Comorbidity: the major challenge for survival and quality of life in end-stage renal disease. Nephrol Dial Transplant. 1998;13 suppl 1:76-9.
22. Hailpern SM, Melamed ML, Cohen HW, Hostetter TH. Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol. 2007;18:2205-13.
23. Walker SR, Gill K, Macdonald K, Komenda P, Rigatto C, Sood MM, et al. Association of frailty and physical function in patients with non-dialysis CKD: a systematic review. BMC Nephrol. 2013;14:228.
24. Winearls CG, Glassock RJ. Dissecting and refining the staging of chronic kidney disease. Kidney Int. 2009;75:1009-14.
25. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80(1):93-104.
26. Go AS, Chertow GM, Fan DJ, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-305.
27. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421-6.
28. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073-81.
29. Gullion CM, Keith DS, Nichols GA, Smith DH. Impact of comorbidities on mortality in managed care patients with CKD. Am J Kidney Dis. 2006;48:212-20.
30. St Peter WL, Wazny LD, Patel UD. New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management. Curr Opin Nephrol Hypertens. 2013;22(6):656-62.
31. Chang YP, Huang SK, Tao P, Chien CW. A population-based study on the association between acute renal failure (ARF) and the duration of polypharmacy. BMC Nephrol. 2012;13:96.
32. de Lissovoy G. Measuring the burden of illness for end-stage renal disease: some heavy lifting required. Kidney Int. 2007;72:1045-7.
33. Jassal SV, Watson D. Dialysis in late life: benefit or burden. Clin J Am Soc Nephrol. 2009;4:2008-12.
34. Mansilla Francisco JJ, Díez De los Ríos Cuenca F, Cabrera Azaña S, Cortés Torres J, Macías López MJ, González Castillo JA, et al. Impact of incident comorbidity on functional loss in elderly chronic kidney disease patients undergoing hemodialysis. CANNT J. 2012;22:25-9.
35. Gallacher K, Morrison D, Jani B, Macdonald S, May CR, Montori VM, et al. Uncovering treatment burden as a key concept for stroke care: a systematic review of qualitative research. PLoS Med. 2013;10:e1001473.
36. Mair FS, May CR. Thinking about the burden of treatment. BMJ. 2014;349:g6680.
37. Fraser SD, Roderick PJ, Casey M, Taal MW, Yuen HM, Nutbeam D. Prevalence and associations of limited health literacy in chronic kidney disease: a systematic review. Nephrol Dial Transplant. 2013;28:129-37.
38. Singleton N, Bumpstead R, O'Brien M, Lee A, Meltzer H. Psychiatric morbidity among adults living in private households. Int Rev Psychiatry. 2003;15:65-73.
39. Health Survey for England - 2011. Health, social care and lifestyles. London: Health and Social Care Information Centre; 2012.
40. Hughes LD, McMurdo ME, Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing. 2013;42(1):62-9.
41. Boyd CM, McNabney MK, Brandt N, Correa-de-Araujuo R, Daniel KM, Epplin J, et al. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc. 2008;60:E1-E25.
42. Guthrie B, Saultz JW, Freeman GK, Haggerty JL. Continuity of care matters. BMJ. 2008;337:a867.